Develop a dissolution method using USP IV (Flow-Through Cell), and, if applicable, Apparatus II (Paddle) or any other appropriate method, for comparative evaluation by the Agency Levetiracetam T.S. Nithiyananthan et al/Int.J. ChemTech Res.2009,1(4) 1279 after finishing6. Tamsulosin is a selective, potent and competitive α 1 – adrenoreceptor antagonist and has a Modified release is used herein in a broad sense and means any dosage form that is not an immediate release dosage form; i.e., not a dosage form that releases in a dissolution test at least 75% of the tamsulosin within the first 30 minutes in a standard dissolution test (i.e. USP apparatus 2, paddles at 50 rpm, with 500 ml SGF at 37°C). The tablets exhibit a reduced food effect in. Comparative dissolution studies of an extended release Formulation of Tolterodine Tartrate and Tamsulosin HCl Article (PDF Available) · February 2013 with 1,606 Reads Cite this publication Contains Nonbinding Recommendations Guidance on Tamsulosin Hydrochloride This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. Formulation development and evaluation of Tamsulosin Hydrochloride and Dutasteride in tablet dosage form V. Ravichandiran, K. Masilamani, K. Punitha, S. Sureshkumar, B. Senthilnathan* Dissolution Test 10 and the Assay Procedure 10 corresponding to this dissolution test for a drug product approved by the FDA. This procedure was validated using an XTerra RP 18 brand of L1 column. The typical retention time for tamsulosin is about 5 minutes. The Tamsulosin Hydrochloride Capsules Revision Bulletin supersedes the currently official monograph. The Revision Bulletin will be. Dissolution 6.10 Perform the test with 1 capsule of Tamsulosin Hydrochloride Capsules at 50 revolutions per minute according to the Paddle method, using the sinker, using 900 mL of 2nd fluid for dissolution test as the dissolution medium. The efficacy of tamsulosin at the cost of a relatively benign side effect profile has been attributed to receptor selectivity directed at the α 1a and α 1d adrenergic receptor subtypes.